TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 DKK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
3,762
|
4,237 | |
| Financial expenses |
2
|
1 | |
| Earnings before taxes |
517
|
673 | |
| EBITDA |
452
|
666 | |
| Total assets |
6,050
|
6,109 | |
| Current assets |
4,503
|
4,565 | |
| Current liabilities |
632
|
630 | |
| Equity capital |
4,996
|
5,080 | |
| - share capital |
63
|
70 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
82.6%
|
83.2% | |
| Turnover per employee |
3,762
|
4,237 | |
| Profit as a percentage of turnover |
13.7%
|
15.9% | |
| Return on assets (ROA) |
8.6%
|
11.0% | |
| Current ratio |
712.5%
|
724.6% | |
| Return on equity (ROE) |
10.3%
|
13.2% | |
| Change turnover |
-67
|
1,441 | |
| Change turnover % |
-2%
|
-2%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.